• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of brjopthalBritish Journal of OphthalmologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Br J Ophthalmol. Apr 1998; 82(4): 407–409.
PMCID: PMC1722576

Diabetic retinopathy in Down's syndrome


AIM—To determine the prevalence of diabetic retinopathy in patients with Down's syndrome and diabetes mellitus.
METHOD—Nine patients with Down's syndrome and diabetes mellitus were assessed. Factors recorded included type and duration of diabetes, level of diabetic control, blood pressure, urinalysis, and results of ophthalmological examination.
RESULTS—The duration of diabetes ranged from 8 to 41 years (mean 17.6 years). All had satisfactory glycaemic control and blood pressure measurements on the low side of normal (mean 106.6/70 mm Hg). One patient had early background diabetic retinopathy. The remainder had no evidence of diabetic retinopathy.
CONCLUSION—The low prevalence of diabetic retinopathy in these Down's syndrome patients, despite the long duration, is an interesting finding. It suggests some inherent protective factor against the development of diabetic retinopathy in this patient subgroup.

Keywords: Down's syndrome; retinopathy; diabetes; hypertension

Full Text

The Full Text of this article is available as a PDF (66K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed) 1985 Mar 16;290(6471):811–815. [PMC free article] [PubMed]
  • Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet. 1983 Jan 29;1(8318):200–204. [PubMed]
  • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984 Apr;102(4):520–526. [PubMed]
  • Knowler WC, Bennett PH, Ballintine EJ. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. N Engl J Med. 1980 Mar 20;302(12):645–650. [PubMed]
  • KORNERUP T. Studies in diabetic retinopathy: an investigation of 1,000 cases of diabetes. Acta Med Scand. 1955 Dec 20;153(2):81–101. [PubMed]
  • Jain IS, Luthra CL, Das T. Diabetic retinopathy and its relation to errors of refraction. Arch Ophthalmol. 1967 Jan;77(1):59–60. [PubMed]
  • Rand LI, Krolewski AS, Aiello LM, Warram JH, Baker RS, Maki T. Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med. 1985 Dec 5;313(23):1433–1438. [PubMed]
  • Gay AJ, Rosenbaum AL. Retinal artery pressure in asymmetric diabetic retinopathy. Arch Ophthalmol. 1966 Jun;75(6):758–762. [PubMed]
  • Blankenship GW, Skyler JS. Diabetic retinopathy: a general survey. Diabetes Care. 1978 Mar-Apr;1(2):127–137. [PubMed]
  • Szabo AJ, Stewart AG, Joron GE. Factors associated with increased prevalence of diabetic retinopathy: a clinical survey. Can Med Assoc J. 1967 Aug 5;97(6):286–292. [PMC free article] [PubMed]
  • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1989 Feb;107(2):237–243. [PubMed]
  • Klein R, Klein BE, Moss SE, DeMets DL. Blood pressure and hypertension in diabetes. Am J Epidemiol. 1985 Jul;122(1):75–89. [PubMed]
  • Chase HP, Garg SK, Jackson WE, Thomas MA, Harris S, Marshall G, Crews MJ. Blood pressure and retinopathy in type I diabetes. Ophthalmology. 1990 Feb;97(2):155–159. [PubMed]
  • Lewis JM, Jovanovic-Peterson L, Ahmadizadeh I, Bevier W, Peterson CM, Williams B. The Santa Barbara County diabetic retinopathy screening feasibility study: significance of diabetes duration and systolic blood pressure. J Diabetes Complications. 1994 Jan-Mar;8(1):51–54. [PubMed]
  • Cignarelli M, De Cicco ML, Damato A, Paternostro A, Pagliarini S, Santoro S, Cardia L, De Pergola G, Giorgino R. High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients. Diabetes Care. 1992 Aug;15(8):1002–1008. [PubMed]
  • Kohner EM, Patel V, Rassam SM. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes. 1995 Jun;44(6):603–607. [PubMed]
  • Patel V, Rassam S, Newsom R, Wiek J, Kohner E. Retinal blood flow in diabetic retinopathy. BMJ. 1992 Sep 19;305(6855):678–683. [PMC free article] [PubMed]
  • Annerén G, Gustafsson J, Sara VR, Tuvemo T. Normalized growth velocity in children with Down's syndrome during growth hormone therapy. J Intellect Disabil Res. 1993 Aug;37(Pt 4):381–387. [PubMed]
  • Barreca A, Rasore Quartino A, Acutis MS, Ponzani P, Damonte G, Miani E, Balestra V, Giordano G, Minuto F. Assessment of growth hormone insulin like growth factor-I axis in Down's syndrome. J Endocrinol Invest. 1994 Jun;17(6):431–436. [PubMed]
  • Castells S, Torrado C, Bastian W, Wisniewski KE. Growth hormone deficiency in Down's syndrome children. J Intellect Disabil Res. 1992 Feb;36(Pt 1):29–43. [PubMed]
  • Alzaid AA, Dinneen SF, Melton LJ, 3rd, Rizza RA. The role of growth hormone in the development of diabetic retinopathy. Diabetes Care. 1994 Jun;17(6):531–534. [PubMed]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...